|
|
 |
|
| Thursday, July 3, 2003 |
| 17:30 - 19:00 |
Satellite symposium organised by
GlaxoSmithKline
The Evolution of Management Options for Chronic Hepatitis |
| |
|
| Friday, July 4, 2003 |
| 19:00 - 20:30 |
Satellite symposium organised by
Bayer Diagnostics
HBV Update : Epidemiology, Therapies and Future Developments
|
| |
|
| Saturday, July 5, 2003 |
| 08:30 - 10:00 |
Satellite symposium organised by
ESSEX Chemie A.G.,Switzerland
How to Maximize HCV Treatment Efficacy: Practical Application
of Results from Landmark Trials
|
| 18:00 - 19:30 |
Satellite symposium organised by
Gilead Sciences
Advances in Chronic Hepatitis B: Treating Diversity of Patients |
| |
|
| Sunday, July 6, 2003 |
| 08:30 - 10:00 |
Satellite symposium organised by
Roche
Seeking the Chance for a Cure in Chronic Hepatitis |
| |
 |
| Thursday, July 3, 2003 |
| 13:00 - 14:00 |
Luncheon symposium organised by
Abbott Diagnostics
Advances in the Management of Chronic HCV Infection: The Challenge
Ahead |
| 13:00 - 14:00 |
Luncheon symposium organised by
Bristol Myers Squibb Company
Controversies in HBV Management: To Treat or Not to Treat
|
| 13:00 - 14:00 |
Luncheon symposium organised by
SciClone Pharmaceuticals
Therapeutic Strategies for HBV / HCV Relapse: The Role of Thymalfasin |
|
|
|
|
Committees
